Certain muscular dystrophies are marked by absence or reduction of mutant p
roteins, foremost dystrophinopathies and sarcoglycanopathies. Conversely, o
ther sporadic and familial neuromuscular conditions are marked by a surplus
of proteins present in a granular or filamentous form, such as desmin-rela
ted myopathies, actinopathy and, perhaps, hyaline body myopathy. This emerg
ing group of congenital myopathies is clinically, immunohistochemically, an
d genetically diverse. Clinically, early- and late-onset diseases with vari
able courses are described. Immunohistochemically, mutant gene-related and
other proteins have been identified by immunohistochemistry. Mutations in t
he desmin and alpha -B crystallin genes have been discovered in desminopath
ies. Mutations in the actin gene, but in no other genes have been revealed
in actinopathy. Surplus sarcoplasmic and/or intranuclear nemaline bodies ha
ve been related to mutant tropomyosin-3, actin and nebulin genes. This emer
ging concept of surplus protein myopathies will require substantial investi
gation to further interpret the results of present and future studies. (C)
2001 Elsevier Science B.V. All rights reserved.